Cargando…

MRI Screening for Optic Gliomas in Neurofibromatosis Type 1

Investigators from Cincinnati Children's Hospital, OH, analysed retrospectively the utility of screening brain/orbital MRIs in 826 children with NF1 (ages 1-9 years; 402 female, 424 male) seen over a 20-year period between 1990 and 2010.

Detalles Bibliográficos
Autor principal:	Millichap, J. Gordon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pediatric Neurology Briefs Publishers 2015
Materias:	Neurocutaneous Syndromes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747284/ https://www.ncbi.nlm.nih.gov/pubmed/26933608 http://dx.doi.org/10.15844/pedneurbriefs-29-9-7

Ejemplares similares

Predictive Power of EEG in Infants with Tuberous Sclerosis
por: Tracy, Molly
Publicado: (2016)

Visual Processing in Infants with Tuberous Sclerosis Complex
por: Gertler, Tracy S., et al.
Publicado: (2016)

Diffusion Tensor Imaging of Epileptogenic Lesions in TSC
por: Mithal, Divakar, et al.
Publicado: (2016)

Imaging of Glutamate Concentration in Sturge-Weber Syndrome
por: Gertler, Tracy S., et al.
Publicado: (2017)

Tuberous Sclerosis Complex: A Roadmap for Future Research
por: Jeong, Anna
Publicado: (2016)

Predicting and Preventing Epilepsy in Sturge-Weber Syndrome?
por: Juhász, Csaba
Publicado: (2016)

Tuberous Sclerosis Complex: Early Diagnosis in Infants
por: Nelson, Stephen L., et al.
Publicado: (2018)

Epilepsy and TSC-Associated Neuropsychiatric Disorders
por: Capal, Jamie K.
Publicado: (2020)

NFB-17. "Optic Pathway findings in children with Neurofibromatosis type-1 (NF-1)
por: Roka, Kleoniki, et al.
Publicado: (2022)

NFB-21. Neurofibromatosis Type I in the Setting of Neuro-Oncology
por: Hemenway, Molly
Publicado: (2022)

NFB-03. Neurological manifestations in children and adolescents with Neurofibromatosis type 1 - Implications for management and surveillance
por: Angelova-Toshkina, Daniela, et al.
Publicado: (2022)

NFB-08. TRAM-01: A Phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
por: Kiaei, Dorsa Sadat, et al.
Publicado: (2022)

NFB-15. "Cognitive Impairments in Children and Adolescents with Neurofibromatosis"
por: Mavrea, Kalliopi, et al.
Publicado: (2022)

NFB-04. Evaluating focal areas of signal intensity (FASI) in children with neurofibromatosis type-1 (NF1) treated with selumetinib on PBTC-029B
por: Pillay Smiley, Natasha, et al.
Publicado: (2022)

Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

NFB-02. Maternal high-fat diet exposure increases the proliferation and glial differentiation of the cells of origin for NF1-optic glioma
por: Zhang, Kailong, et al.
Publicado: (2022)

Do you know this syndrome? Type 2 benign symmetric lipomatosis (Launois-Bensaude)
por: Esposito, Ana Cláudia Cavalcante, et al.
Publicado: (2016)

Salivary Gland Mucosa‐Associated Lymphoid Tissue–Type Lymphoma From Sjögren’s Syndrome Patients in the Majority Express Rheumatoid Factors Affinity‐Selected for IgG
por: Bende, Richard J., et al.
Publicado: (2020)

Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma
por: Boonzaier, Natalie R., et al.
Publicado: (2020)

Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
por: Hedlund, Malin, et al.
Publicado: (2020)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1
por: Zeid, Janice Lasky
Publicado: (2022)

Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
por: Tang, Yunshuo, et al.
Publicado: (2023)

Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
por: Hillen, Maarten R, et al.
Publicado: (2020)

Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren’s syndrome
por: Broeren, Mathijs G A, et al.
Publicado: (2022)

SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
por: Rose, Thomas, et al.
Publicado: (2016)

De novo, heterozygous, loss‐of‐function mutations in SYNGAP1 cause a syndromic form of intellectual disability
por: Parker, Michael J., et al.
Publicado: (2015)

Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren’s syndrome
por: Norheim, Katrine Brække, et al.
Publicado: (2021)

Optic pathway glioma, scoliosis, Chiari type 1 malformation, and syringomyelia in a patient with neurofibromatosis type 1
por: Incecık, Faruk, et al.
Publicado: (2013)

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study
por: Henning, Anne Munk, et al.
Publicado: (2021)

Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
por: Blokland, Sofie L M, et al.
Publicado: (2019)

Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sjögren’s syndrome
por: Zheng, Qing, et al.
Publicado: (2023)

Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations
por: Cassina, Matteo, et al.
Publicado: (2019)

RONC-05. PRESERVING VISION IN OPTIC PATHWAY GLIOMA AMONG PATIENTS WITHOUT NEUROFIBROMATOSIS TYPE 1
por: Hanania, Alexander, et al.
Publicado: (2020)

Global Public Health Burden of Heart Failure: An Updated Review
por: Shahim, Bahira, et al.
Publicado: (2023)

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
por: Kapelios, Chris J, et al.
Publicado: (2023)

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy
por: Bezzina, Oriana M., et al.
Publicado: (2017)

Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort
por: Bot, M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kamrtkrkf2idq50nda838ou735